Showing 9171-9180 of 18562 results for "".
- Innovative Management of Larotrectinib Withdrawal Symptoms Using GLP-1 Receptor Agonistshttps://reachmd.com/news/innovative-management-of-larotrectinib-withdrawal-symptoms-using-glp-1-receptor-agonists/2484079/A recent case report describes resolution of larotrectinib withdrawal symptoms after starting semaglutide, a GLP‑1 receptor agonist — an observation with immediate relevance for supportive care teams. The patient developed diffuse, withdrawal‑like myalgias and arthralgias in the set
- Inflammation and Pain in Neurocritical Care: New Insights from Recent Researchhttps://reachmd.com/news/inflammation-and-pain-in-neurocritical-care-new-insights-from-recent-research/2484056/A recent study found that early systemic inflammatory markers did not predict ICU pain burden after aneurysmal subarachnoid hemorrhage (SAH); instead
- Early Peanut Introduction: Real-World Evidence of Allergy Prevention Benefitshttps://reachmd.com/news/early-peanut-introduction-real-world-evidence-of-allergy-prevention-benefits/2484059/Primary-care EHR data show a substantial drop in clinician-diagnosed peanut and overall IgE-mediated food allergies after the 2015 early-introduction guideline and its 2017 addendum. According to the recent
- Exploring Epigenetic Mechanisms in Asthma Recurrence: The Role of Brg1 in ILC2 Regulationhttps://reachmd.com/news/exploring-epigenetic-mechanisms-in-asthma-recurrence-the-role-of-brg1-in-ilc2-regulation/2484071/According to a report, preclinical researchers identify the chromatin remodeler Brg1 (Smarca4) as a central regulator of Group
- Demographic Considerations in Diagnosing Interstitial Ectopic Pregnancyhttps://reachmd.com/news/demographic-considerations-in-diagnosing-interstitial-ectopic-pregnancy/2484074/A new retrospective study out of Boston Medical Center has shed light on a persistent diagnostic challenge in reproductive medicine: the misdiagnosis of interstitial ectopic pregna
- Examining Nerandomilast Efficacy in Idiopathic Pulmonary Fibrosis: Insights from CHEST 2025https://reachmd.com/news/examining-nerandomilast-efficacy-in-idiopathic-pulmonary-fibrosis-insights-from-chest-2025/2484078/Nerandomilast (Jascayd) slowed forced vital capacity (FVC) decline over 52 weeks in the FIBRONEER‑IPF Phase 3 trial
- Dual-Energy CT Enhances Image Quality for Liver Metastases Without Increasing Detectionhttps://reachmd.com/news/dual-energy-ct-enhances-image-quality-for-liver-metastases-without-increasing-detection/2484047/A recent retrospective study has evaluated the clinical performance of dual-energy CT (DECT) in imaging hypovascular liver metastases, focusing on image quality and diagnostic utility. Condu
- Harnessing Radiomics: Enhancing Prognosis in Pulmonary Embolism via Thrombus Imaginghttps://reachmd.com/news/harnessing-radiomics-enhancing-prognosis-in-pulmonary-embolism-via-thrombus-imaging/2484057/A new primary study identifies CT-derived thrombus radiomics as a robust prognostic tool, demonstrating that thrombus imaging materially improves ris
- AI System Identifies Surgical Phases in Robot-Assisted Prostatectomy Across Multiple Surgeonshttps://reachmd.com/news/ai-system-identifies-surgical-phases-in-robot-assisted-prostatectomy-across-multiple-surgeons/2484044/Researchers at Keio University School of Medicine have developed and validated an artificial intelligence (AI) model for automated recognition of surgical phases in robot-assisted radical prostatectomy (RARP). The
- Systemic Inflammation Markers: No Predictor for Pain in SAHhttps://reachmd.com/news/systemic-inflammation-markers-no-predictor-for-pain-in-sah/2484052/A recent multicenter study found that early systemic inflammatory markers did not predict subsequent ICU pain burden after aneurysmal subarachnoid hemorrhage (SAH), a finding